Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Bladder Cancer

Free Subscription 14.10.2019 1 Biochem Cell Biol 1 BJU Int 1 Bull Cancer 1 Cancer Biomark 1 Cancer Radiother 1 Cancers (Basel) 1 Clin Genitourin Cancer 1 Environ Toxicol 1 Int J Biol Sci 2 Int J Cancer 1 Int J Urol 1 J Cancer Res Clin Oncol 1 J Clin Invest 1 Mol Biol Rep 1 Nutr Cancer 1 Pan Afr Med J 3 Urol Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Biochem Cell Biol

1. LI G, Sun L, Mu Z, Liu S, et al
   MicroRNA-1298-5p inhibits cell proliferation and invasion of bladder cancer via downregulating connexin 43.
   Biochem Cell Biol. 2019 Oct 10. doi: 10.1139/bcb-2019-0137.
   PubMed     Text format     Abstract available
   
   

   
   BJU Int

2. TAYLOR J, Becher E, Steinberg GD
   Update on the Guideline of Guidelines: Non-Muscle Invasive Bladder Cancer.
   BJU Int. 2019 Oct 9. doi: 10.1111/bju.14915.
   PubMed     Text format     Abstract available
   
   

   
   Bull Cancer

3. OUEDRAOGO S, Traore MT, Kambire JL, Ouedraogo S, et al
   [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
   Bull Cancer. 2019;106:868-874.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Biomark

4. LIU A, Xue Y, Liu F, Tan H, et al
   Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
   Cancer Biomark. 2019 Sep 27. pii: CBM182143. doi: 10.3233/CBM-182143.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Radiother

5. BRIENS A, Castelli J, Barateau A, Jaksic N, et al
   [Adaptive radiotherapy: Strategies and benefits depending on tumor localization].
   Cancer Radiother. 2019;23.
   PubMed     Text format     Abstract available
   
   

   
   Cancers (Basel)

6. PARK C, Cha HJ, Choi EO, Lee H, et al
   Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells.
   Cancers (Basel). 2019;11.
   PubMed     Text format     Abstract available
   
   

   
   Clin Genitourin Cancer

7. GRONOSTAJ K, Czech AK, Fronczek J, Drobniak A, et al
   The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy.
   Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30272.
   PubMed     Text format     Abstract available
   
   

   
   Environ Toxicol

8. TSAI TF, Chen PC, Lin YC, Chou KY, et al
   Benzyl isothiocyanate promotes miR-99a expression through ERK/AP-1-dependent pathway in bladder cancer cells.
   Environ Toxicol. 2019 Oct 6. doi: 10.1002/tox.22841.
   PubMed     Text format     Abstract available
   
   

   
   Int J Biol Sci

9. ZHOU Q, Chen S, Lu M, Luo Y, et al
   EFEMP2 suppresses epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human bladder cancer.
   Int J Biol Sci. 2019;15:2139-2155.
   PubMed     Text format     Abstract available
   
   

   
   Int J Cancer

10. ZENG H, Liu Z, Wang Z, Zhou Q, et al
    Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32715.
    PubMed     Text format     Abstract available
    
    
11. JACK S, Madhivanan K, Ramadesikan S, Subramanian S, et al
    A Novel, Safe, Fast, Efficient Treatment for Her2-positive and Negative Bladder Cancer Utilizing an EGF-Anthrax Toxin Chimera.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32719.
    PubMed     Text format     Abstract available
    
    

    
    Int J Urol

12. MATSUMOTO H
    Editorial Comment from Dr Matsumoto to Intraoperative hypotension caused by oral administration of 5-aminolevulinic acid for photodynamic diagnosis in patients with bladder cancer.
    Int J Urol. 2019 Oct 6. doi: 10.1111/iju.14131.
    PubMed     Text format    
    
    

    
    J Cancer Res Clin Oncol

13. PAPADIMITRIOU MA, Avgeris M, Levis PK, Tokas T, et al
    DeltaNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
    J Cancer Res Clin Oncol. 2019 Oct 8. pii: 10.1007/s00432-019-03028.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Invest

14. CHEN C, Luo Y, He W, Zhao Y, et al
    Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer.
    J Clin Invest. 2019 Oct 8. pii: 130892. doi: 10.1172/JCI130892.
    PubMed     Text format     Abstract available
    
    

    
    Mol Biol Rep

15. ROUDAFSHANI Z, Jazayeri MH, Mahmoudi AR, Nedaeinia R, et al
    Evaluation of the frequency of CD5(+) B cells as natural immunoglobulin M producers and circulating soluble CD5 in patients with bladder cancer.
    Mol Biol Rep. 2019 Oct 5. pii: 10.1007/s11033-019-05087.
    PubMed     Text format     Abstract available
    
    

    
    Nutr Cancer

16. CHESTNUT C, Smelser W, Dum T, Bechtel M, et al
    Glycemic impact of a diet and lifestyle intervention on diabetics and prediabetics during treatment for non-muscle invasive bladder cancer.
    Nutr Cancer. 2019 Oct 7:1-6. doi: 10.1080/01635581.2019.1672761.
    PubMed     Text format     Abstract available
    
    

    
    Pan Afr Med J

17. KASANGA TK, Ntanga DI, Musapoudi EM, Kapessa ND, et al
    [Recurrent invasive bladder urothelial carcinoma treated by cystectomy with substitutive ileal enterocystoplasty: case report].
    Pan Afr Med J. 2019;33:184.
    PubMed     Text format     Abstract available
    
    

    
    Urol Oncol

18. CARRION A, Huguet J, Ribal MJ, Dominguez A, et al
    Comparison of standard vs. palliative management for bladder cancer in patients older than 85 years: multicenter study of 317 de novo tumors.
    Urol Oncol. 2019 Oct 2. pii: S1078-1439(19)30358.
    PubMed     Text format     Abstract available
    
    
19. GENITSCH V, Kollar A, Vandekerkhove G, Blarer J, et al
    Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Urol Oncol. 2019 Oct 1. pii: S1078-1439(19)30376.
    PubMed     Text format     Abstract available
    
    
20. BURGESS EF, Livasy C, Trufan S, Hartman A, et al
    High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
    Urol Oncol. 2019 Oct 6. pii: S1078-1439(19)30360.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: